Page last updated: 2024-08-24

rogletimide and Menopause

rogletimide has been researched along with Menopause in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coombes, RC; Dowsett, M; Haynes, B; Jarman, M; Jones, A; Lonning, P; MacNeill, F; Mehta, A; Newton, C; Powles, TJ1
Dowsett, M; Lønning, PE; Powles, TJ1

Reviews

1 review(s) available for rogletimide and Menopause

ArticleYear
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Journal of steroid biochemistry, 1990, Volume: 35, Issue:3-4

    Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles

1990

Trials

1 trial(s) available for rogletimide and Menopause

ArticleYear
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.
    British journal of cancer, 1991, Volume: 64, Issue:5

    Topics: Aged; Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Biological Availability; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Hormones; Humans; Menopause; Middle Aged

1991